Fast and accurate detection of swine influenza using Seegene’s Seeplex

Seeegene, Inc., a local biotechnology company specialized in molecular diagnostics and research applications, said on June 12 that the Seoul National University Hospital confirmed additional patients with H1N1 influenza A using its “Seeplex," which sets a standard in high-throughput and simultaneous multi-pathogen detection called "multiplexing."

Currently, Seeplex multi-pathogen detection t...